ArticleRadiology case reports2026
Localised malignant mesothelioma presenting as an esophageal mass: An unusual manifestation.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant mesothelioma is an aggressive neoplasm arising from mesothelial cells, typically presenting with pleural thickening, pleural effusions, or respiratory symptoms. Dysphagia as a presenting symptom is extremely uncommon, and esophageal involvement is rare. We report a 71-year-old male with an 18-month history of progressive dysphagia and significant weight loss. Initial gastroscopy was unremarkable, but repeat endoscopy revealed a smooth lower esophageal stricture. Contrast-enhanced CT demonstrated a well-circumscribed esophageal mass with minimal pleural thickening, and PET-CT confirmed high FDG uptake in the mass and subtle anterior and posterior mediastinal pleural foci. Endoscopic ultrasound-guided fine-needle aspiration of the esophageal lesion revealed epithelioid cells positive for mesothelial markers (CK5, D2-40, WT1, Calretinin, CK7) with loss of BAP1 and MTAP, consistent with epithelioid mesothelioma. The patient was commenced on immunotherapy but lost to follow-up. This case represents an unusual manifestation of localized malignant mesothelioma presenting primarily as an esophageal mass, with minimal pleural disease. The diagnosis was established via endoscopic ultrasound-guided fine-needle aspiration, highlighting the utility of minimally invasive techniques in atypical presentations. It underscores the importance of considering mesothelioma in the differential diagnosis of unexplained esophageal or mediastinal masses, even in the absence of classic pleural findings. Mesothelioma can rarely present with dominant esophageal involvement. Awareness of this atypical presentation facilitates timely diagnosis, appropriate management, and may prevent diagnostic delays in patients presenting with dysphagia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.